Emerging pharmacological therapies for ARDS: COVID-19 and beyond

ARDS, first described in 1967, is the commonest form of acute severe hypoxemic respiratory failure. Despite considerable advances in our knowledge regarding the pathophysiology of ARDS, insights into the biologic mechanisms of lung injury and repair, and advances in supportive care, particularly ven...

Descripción completa

Detalles Bibliográficos
Autores principales: Horie, Shahd, McNicholas, Bairbre, Rezoagli, Emanuele, Pham, Tài, Curley, Ger, McAuley, Danny, O’Kane, Cecilia, Nichol, Alistair, dos Santos, Claudia, Rocco, Patricia R. M., Bellani, Giacomo, Laffey, John G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Narrative Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352097/
https://www.ncbi.nlm.nih.gov/pubmed/32654006
http://dx.doi.org/10.1007/s00134-020-06141-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352097/
https://www.ncbi.nlm.nih.gov/pubmed/32654006
http://dx.doi.org/10.1007/s00134-020-06141-z

Ejemplares similares